Peptides are suddenly everywhere – on social media, in wellness clinics, and in conversations about sleep, skin, immunity, and longevity. They sound scientific, modern, and promising. But what exactly are peptides, and how much of the hype is grounded in real medicine? This article breaks down the basics in a clear, practical way, helping patients understand what peptides are, how they’re used, and what to consider before exploring “peptide therapy.”
A very special thank you to Dr Debbie Norval, Dr Heidi Frere, Dr Danny Meyersfeld and Dr Walter Bell for their sound and valuable input in this article.




What are peptides, really?
Peptides are short chains of amino acids – the same building blocks that make up proteins in the body. Think of them as small messenger molecules that help cells communicate. Some peptides influence hormones, some affect immune responses, and others play a role in tissue repair or metabolism.
Importantly, “peptide” does not mean “natural,” “safe,” or “proven.” It simply describes the structure of the molecule.
Some of the most important medicines in the world are peptides, including insulin for diabetes and certain hormone therapies. So peptides, as a category, are scientifically legitimate. The key questions are:
- Which peptide?
- For what purpose?
- With what evidence?
- From what source?

Why peptides are trending in the wellness world
The rise of peptide popularity is not random. Several trends have converged:
- Modern injectable medicines (like GLP-1 therapies i.e Ozempic) have made peptides feel cutting-edge.
- Biohacking – a trend where people experiment with supplements, devices, and sometimes medications to try to “optimise” their bodies and performance – has also contributed to the popularity of peptides, particularly in the longevity and wellness space.
- Social media makes complex science look simple and accessible
- Some peptides are sold as “research use only,” creating a sense of exclusivity
The result is a growing perception that peptides are a quick route to better sleep, faster recovery, improved mood, or even anti-ageing benefits.
GLP-1 peptides and metabolic treatments in South Africa
Dr Heidi Frere says:
One group of peptides that has received significant medical attention are GLP-1 receptor agonists (e.g. Ozempic, Mounjaro), which are used in the management of type 2 diabetes and, in some cases, medical weight management. These include medicines such as semaglutide-based and dual-hormone combination therapies prescribed under strict medical supervision.
In South Africa, these treatments are regulated and prescribed for specific indications. They are not lifestyle or cosmetic interventions, and they require proper screening, monitoring, and medical oversight.
Dr Debbie Norval and Dr Walter Bell expand:
More recently, certain GLP-1 receptor agonists have received formal FDA approval for indications beyond diabetes care. Semaglutide (Wegovy) and Tirzepatide (Mounjaro) are both FDA-approved for chronic weight management in appropriate patients, in addition to their roles in type 2 diabetes management.
Semaglutide (Wegovy) has also received FDA approval for reducing the risk of major cardiovascular events such as heart attack and stroke in adults with obesity or overweight and established cardiovascular disease. Further indications include treatment for a serious form of fatty liver disease, as well as for slowing down worsening kidney damage in adults who have type 2 diabetes and chronic kidney disease.
Tirzepatide (Mounjaro) has additionally received FDA approval for moderate-to-severe obstructive sleep apnoea (OSA) in adults with obesity.
This reflects how rapidly the science in this area is evolving, and how metabolic peptides are increasingly recognised for their broader systemic impact beyond glucose control alone.
While their success has increased public interest in peptides overall, GLP-1 medicines should not be confused with experimental “wellness peptides” promoted online for general health or anti-ageing.
To learn more about these GLP-1s and the ones available in South Africa, read this article by Dr Heidi Frere.
How are peptides taken?
Most therapeutic peptides are not taken as tablets because the digestive system breaks them down like food protein.
They are commonly administered as:
- Subcutaneous injections (under the skin)
- Intramuscular injections
- Nasal sprays (for specific peptides)
This makes them more comparable to prescription medicines than to supplements.
Peptides in powder or capsule form (such as collagen peptides) are usually used for nutritional purposes, not for targeted medical effects.
The difference between medical peptides and “wellness peptides”
There are two very different worlds in peptide use.
1. Regulated medical peptides
These have formal approval, quality control, and clinical evidence for specific conditions. Examples include insulin and certain immune-modulating peptides used in specialist care.
2. Wellness and longevity peptides
These are often promoted for:
- Sleep support
- Injury recovery
- Anxiety or focus
- Immune “boosting”
- Fat loss or metabolism
- Anti-ageing
Some have early research behind them. Many do not have strong human clinical trials for the claims being made.
This does not mean they are useless – but it does mean the science is still evolving.
Dr Danny Meyersfeld adds:
It may well be argued that there exists a third category of peptides: those that have been used in clinical practice for many years, that have developed a substantial body of anecdotal evidence to support some of their benefits, but are not yet fully regulated or supported by clinical trials. This is particularly evident in the USA, where the majority of pharmaceuticals are already used “off-label”, and physicians have been using peptides clinically for some time. The quality and source of the peptides remain critically important.
Popular peptides you may see online
Here is a simplified overview of commonly marketed peptides and how they are often positioned.
For sleep and ageing
DSIP, Epitalon
These are frequently discussed in longevity circles. Outside of niche research contexts, they are not mainstream, widely approved sleep treatments.
For mood and focus
Selank, Semax
Popular in some countries and online communities. Human evidence for anxiety and cognitive claims is limited compared to conventional therapies.
For injury and inflammation
BPC-157, TB-500
Much of the enthusiasm comes from animal and laboratory research. Human clinical data is still relatively limited.
For immune support
Thymosin alpha-1
This peptide has a stronger clinical history in certain medical contexts internationally, but immune modulation is not a casual wellness intervention and should always be clinician-guided.
For metabolism and fat loss
MOTS-c, AOD-9604
Frequently promoted in biohacking spaces. These sit largely in the experimental category, depending on jurisdiction and formulation.

The real risks patients don’t always see
1. Product quality and safety
Injectable peptides must be manufactured, stored, and administered under strict medical standards. Poor quality products increase the risk of:
- Infection
- Contamination
- Incorrect dosing
- Immune reactions
The dangers of poorly sourced products
Dr Debbie Norval:
Not all peptide products are manufactured to pharmaceutical standards. Poorly sourced or illegally imported products may contain incorrect dosages, impurities, or contaminants, and may not be sterile.
When peptides are injected, these risks increase significantly. Infections, inflammatory reactions, and unpredictable side effects can occur when products are not produced, stored, and administered under strict medical conditions.
2. “Stacking” multiple peptides
Some clinics promote peptide “stacks” for multiple outcomes at once. This makes side effects harder to identify and increases uncertainty around interactions.
Dr Danny Meyersfeld says: In addition, different peptides function optimally at different pH levels; by creating a “stack”, compromises need to be made about the optimal pH to use, and how that affects the peptide activity is largely unknown.
Peptides also do not act in isolation within the body. They interact with broader hormonal systems, including insulin, thyroid hormones, cortisol, and sex hormones. Without proper assessment and monitoring, adding multiple therapies can lead to unintended effects rather than improved outcomes. For example, stimulating growth hormone pathways without the rest of the hormonal environment being balanced may result in fatigue or disappointing results rather than improvement.
3. Over-promising
Claims about reversing ageing, balancing hormones, or “optimising everything” often go far beyond what science can currently guarantee.
Cost, accessibility, and ethical concerns
Dr Debbie Norval says:
Some peptide treatments can be expensive. For certain patients, this may create unrealistic financial pressure, especially when the benefits of some peptides are not clearly supported by strong clinical evidence.
There is also a risk that vulnerable, desperate, or impressionable individuals – including those struggling with chronic health issues, body image concerns, ageing anxiety, fertility and athletes – may be targeted by persuasive marketing.
Dr Heidi Frere adds:
This space is particularly influenced by personal testimonials and before-and-after stories, which can feel compelling but do not replace proper medical evidence.
Ethical medical practice should always prioritise patient wellbeing over trends, profit, or promises of rapid transformation.

What regulation means for patients
In South Africa and globally, regulators are paying closer attention to compounded medicines and injectable wellness products.
In South Africa, the main regulatory authority is the South African Health Products Regulatory Authority (SAHPRA), which is responsible for ensuring that medicines meet standards for quality, safety, and effectiveness. A SAHPRA-registered medicine has been formally evaluated and monitored.
Compounded medicines may be legally prepared for a specific patient under certain conditions, but are not assessed by SAHPRA in the same way as registered products.
Products that are poorly sourced, or sold online as “research chemicals” or through informal channels, fall outside normal regulatory oversight and should be considered high risk.
Patients should never purchase injectable peptides online or from non-medical suppliers.
If a peptide is not a registered medicine, it should still be sourced, prescribed, and administered responsibly by a qualified medical professional.
Casual online sales, i.e., from personal trainers and gym instructors, are a red flag. Patients may think it’s “safe” as these individuals are into fitness and health. Nor should one purchase peptides from your aunty’s cousin’s Facebook Page in Bloemfontein, another red flag!
When a product has not been evaluated by the regulator, its contents, dose accuracy, and sterility cannot be guaranteed, which significantly increases the risk of harm.
Patients should never feel pressured into treatments without proper explanation, informed consent, and medical oversight.
In a fast-moving online world, hesitation is sometimes mistaken for outdated thinking. Influencers can adopt new therapies overnight; doctors can’t — because clinicians carry responsibility for quality, safety, legality, and long-term outcomes. Careful adoption is often not resistance to progress; it’s critical thinking and protection of the patient.
What to ask before starting peptide therapy
A trustworthy provider should be able to answer these clearly:
- Is this peptide a registered medicine in this country?
- What human clinical evidence supports its use for my concern?
- Where is it sourced, and how is quality verified?
- What are the risks and side effects?
- What monitoring is required?
- Why this option instead of standard treatments?
If the answers feel vague, overly sales-driven, or dismissive of risks, it is worth pausing.
Dr Heidi Frere adds:
Appropriate peptide therapy usually requires baseline blood tests and follow-up monitoring. This helps assess safety, check for interactions with existing conditions or medications, and determine whether the treatment is actually helping. Treatments offered without any form of medical monitoring should be avoided.
The balanced truth
Peptides are not “fake.”
They are not “miracle cures.”
They are powerful biological tools that require careful, ethical, and evidence-based use.
Some peptides have real medical value. Others are still being explored.
Medical understanding develops over years, not months, and wider use sometimes reveals effects that were not obvious in early studies.
Even with well-studied medications such as GLP-1 therapies, long-term outcomes are still being observed in real-world populations, and ongoing monitoring remains important as broader use increases.
The responsibility lies in how they are prescribed, marketed, and understood.
For patients, informed curiosity is healthy. Blind optimism is not.
Final word for patients
If you are interested in peptides, start with education, not injections. Speak to a qualified doctor who understands both the science and the limits of current evidence.
Good medicine does not promise perfection. It prioritises safety, transparency, and long-term well-being.
About the author
Rochelle is the founder and driving force behind the Aesthetic Appointment Journal. With a passion for the aesthetics and pro-ageing industry in South Africa, she has been in the aesthetic publishing industry since 2012, dedicated to creating a valuable platform for insights and knowledge, bridging the gap between patients and doctors - delivering reliable, medical-based information. Rochelle firmly believes in the power of a good skincare regimen, especially when started at home, and is committed to educating consumers about the myriad of treatments, procedures, and products available to them.
MBBCh (Rand) Dip Pall Med (cUK) M Phil Pall Med (UCT) Adv Dip Aesthetic Med (FPD)
Dr Debbie Norval graduated as a medical doctor from the University of the Witwatersrand, in 1991. Post graduate training includes a Diploma in Palliative Medicine through the University of Wales, Masters of Philosophy from the University of Cape Town, an Advanced Diploma in Aesthetic Medicine through the Foundation for Professional Development and a City and Guilds Diploma in Adult Teaching and Training.
Dr Norval is the convenor of the Johannesburg Aesthetic Doctors Journal Club and previously sat on the scientific committee of the Aesthetic Medicine Congress of South Africa (AMCSA). She is the Past President of the Aesthetic and Anti-Aging Medicine Society of South Africa (AAMSSA) and also served on the International Advisory Board of CMAC (Complications in Medical Aesthetics Collaborative).
“Dr Debbie Norval Aesthetics” is a busy clinical practice in Parktown North, Johannesburg.
Please note Dr Debbie is not taking on new patients at this time.
MBChB, Advanced Diploma in Aesthetic Medicine (Cum Laude)
Dr Heidi Frere is the Founder and Medical Director of Best You Medical Wellness & Aesthetics in Douglasdale, Johannesburg. With over 25 years of medical experience, she combines her extensive clinical background with a passion for holistic wellness. Dr Frere holds an MBChB and an Advanced Diploma in Aesthetic Medicine (Cum Laude), and has developed a special interest in medical aesthetics, functional medicine, hormone replenishment, and medical weight management.
Dr Danny Meyersfeld completed his PhD in Molecular Biology in 2005 at the University of Witwatersrand, South Africa. Following two years of post-doctoral research, and passionate about the concept of personalised medicine, Danny set up DNAlysis Biotechnology, a company dedicated to the widespread adoption of genomic insights into clinical practice.
Danny is passionate about making available to doctors in sub-Saharan Africa the same tools that are available elsewhere in the world and is determined to ensure the appropriate and responsible integration of genetic tests into clinical practice.
To this end, the DNAlysis portfolio of genetic tests has been developed with a focus on scientific integrity and accuracy, and a significant portion of time is spent on the upskilling of medical practitioners to try to ease the transition of complex genetics into medical practices.




